Autologous HB-MSCs

bone marrow-derived mesenchymal stem cells (HB-MSCs) · Hope Biosciences Research Foundation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous HB-MSCs, covering 2025-05-07 to 2025-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis [Phase 2]

See pricing